Literature DB >> 30072446

Circulating miR-148a associates with sensitivity to adiponectin levels in human metabolic surgery for weight loss.

Magnolia Ariza-Nieto1, Joshua B Alley2, Sanjay Samy3, Laura Fitzgerald4, Francoise Vermeylen5, Michael L Shuler6, Jose O Aleman7.   

Abstract

OBJECTIVE: We sought to discover secreted biomarkers to monitor the recovery of physiological adiponectin levels with metabolic surgery, focusing on epigenetic changes that might predict adiponectin function.
DESIGN: We conducted a prospective observational study of patients undergoing metabolic surgery by Roux-en-Y gastric bypass (RYGB) for weight loss in a single center (IRB GHS # 1207-27).
METHODS: All patients (n=33; 27 females; 6 males) signed informed consent. Metabolites, adiponectin, and miR-148a were measured in fasting plasma. We followed MIQE for transcript profiles.
RESULTS: Patients lost on average 47±12% excess BMI (%EBMI) after 12 weeks. Adiponectin pre, post or delta [post minus pre] did not correlate with %EBMIL. A decrease in adiponectin following weight loss surgery was observed in a subset of patients, chi-square test of independence rejects the null hypotheses that the liver DNMT1 and delta adiponectin are independent (Chi-square statistics χ2 38 = 6.9205, P= 0.00852, n=33), as well as miR-148a and delta adiponectin are independent (Chisquare statistics χ2 40 = 9.6823, P= 0.00186, n=33). The presence of plasma miR-148a allows identification of patients that appear to be adiponectin insensitive at baseline.
CONCLUSION: We combined the presence of plasma miR-148a, the concentration of total adiponectin and the expression of DNA methyltransferase 1 (DNMT1) in liver biopsy tissue to identify patients with non-physiological adiponectin. Weight loss and physical activity interventions complemented with the new method presented here could serve to monitor the physiological levels of adiponectin, thought to be important for long-term weight loss maintenance.

Year:  2018        PMID: 30072446     DOI: 10.1530/EC-18-0205

Source DB:  PubMed          Journal:  Endocr Connect        ISSN: 2049-3614            Impact factor:   3.335


  25 in total

1.  MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in gastric cancer.

Authors:  Akao Zhu; Jiazeng Xia; Junbo Zuo; Shimao Jin; Hong Zhou; Lubin Yao; Hongyu Huang; Zhijun Han
Journal:  Med Oncol       Date:  2011-12-14       Impact factor: 3.064

2.  American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery Medical Guidelines for Clinical Practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient.

Authors:  Jeffrey I Mechanick; Robert F Kushner; Harvey J Sugerman; J Michael Gonzalez-Campoy; Maria L Collazo-Clavell; Safak Guven; Adam F Spitz; Caroline M Apovian; Edward H Livingston; Robert Brolin; David B Sarwer; Wendy A Anderson; John Dixon
Journal:  Surg Obes Relat Dis       Date:  2008-08-19       Impact factor: 4.734

Review 3.  Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation.

Authors:  K G M M Alberti; P Zimmet; J Shaw
Journal:  Diabet Med       Date:  2006-05       Impact factor: 4.359

Review 4.  Epigenetic modifiers of islet function and mass.

Authors:  Dario F De Jesus; Rohit N Kulkarni
Journal:  Trends Endocrinol Metab       Date:  2014-09-19       Impact factor: 12.015

5.  Epigenetic reprogramming modulates malignant properties of human liver cancer.

Authors:  Chiara Raggi; Valentina M Factor; Daekwan Seo; Agnes Holczbauer; Matthew C Gillen; Jens U Marquardt; Jesper B Andersen; Marian Durkin; Snorri S Thorgeirsson
Journal:  Hepatology       Date:  2014-05-01       Impact factor: 17.425

6.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.

Authors:  Y Arita; S Kihara; N Ouchi; M Takahashi; K Maeda; J Miyagawa; K Hotta; I Shimomura; T Nakamura; K Miyaoka; H Kuriyama; M Nishida; S Yamashita; K Okubo; K Matsubara; M Muraguchi; Y Ohmoto; T Funahashi; Y Matsuzawa
Journal:  Biochem Biophys Res Commun       Date:  1999-04-02       Impact factor: 3.575

Review 7.  Genetic and epigenetic control of metabolic health.

Authors:  Robert Wolfgang Schwenk; Heike Vogel; Annette Schürmann
Journal:  Mol Metab       Date:  2013-09-25       Impact factor: 7.422

8.  Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1.

Authors:  Joseph T Rodgers; Carlos Lerin; Wilhelm Haas; Steven P Gygi; Bruce M Spiegelman; Pere Puigserver
Journal:  Nature       Date:  2005-03-03       Impact factor: 49.962

9.  Adiponectin secretion is regulated by SIRT1 and the endoplasmic reticulum oxidoreductase Ero1-L alpha.

Authors:  Li Qiang; Hong Wang; Stephen R Farmer
Journal:  Mol Cell Biol       Date:  2007-04-23       Impact factor: 4.272

Review 10.  Coordinated Actions of MicroRNAs with other Epigenetic Factors Regulate Skeletal Muscle Development and Adaptation.

Authors:  Marzia Bianchi; Alessandra Renzini; Sergio Adamo; Viviana Moresi
Journal:  Int J Mol Sci       Date:  2017-04-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.